Literature DB >> 8063222

Gastric cancer risk after vagotomy.

G Lundegårdh1, A Ekbom, J K McLaughlin, O Nyrén.   

Abstract

The risk of gastric cancer after vagotomy for benign gastric and duodenal disease was examined in a population based cohort of 7198 patients operated on during 1971-79 and followed up until 1988. After exclusion of the first year of follow up there were 34 cases of gastric cancer compared with 25.6 expected (standardised incidence ratio (SIR) = 1.33; 95% confidence intervals (CI) 0.92 to 1.86). Separate analyses by duration of follow up, sex, age at operation, underlying diagnosis, and operative procedures did not show any significant increased or decreased risk of gastric cancer in any of the subgroups. In conclusion, decreased gastric acid secretion after vagotomy does not increase the risk of gastric cancer in the first 10 years after operation or in the subgroup followed up for 10-18 years. A longer follow-up is needed before an excess risk can be excluded.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8063222      PMCID: PMC1374842          DOI: 10.1136/gut.35.7.946

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  44 in total

1.  24-hour intragastric acidity and plasma gastrin after omeprazole treatment and after proximal gastric vagotomy in duodenal ulcer patients.

Authors:  T Lind; C Cederberg; M Olausson; L Olbe
Journal:  Gastroenterology       Date:  1990-12       Impact factor: 22.682

2.  Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation.

Authors:  D Forman; D G Newell; F Fullerton; J W Yarnell; A R Stacey; N Wald; F Sitas
Journal:  BMJ       Date:  1991-06-01

3.  Effect of cimetidine on survival after gastric cancer.

Authors:  H Tønnesen; U Knigge; S Bülow; P Damm; K Fischerman; P Hesselfeldt; A Hjortrup; I K Pedersen; V M Pedersen; O J Siemssen
Journal:  Lancet       Date:  1988-10-29       Impact factor: 79.321

4.  Cimetidine use and gastric cancer.

Authors:  M C Schumacher; S S Jick; H Jick; A D Feld
Journal:  Epidemiology       Date:  1990-05       Impact factor: 4.822

5.  Time trends in peptic ulcer surgery, 1956 to 1986. A nation-wide survey in Sweden.

Authors:  S Gustavsson; O Nyrén
Journal:  Ann Surg       Date:  1989-12       Impact factor: 12.969

6.  Cancer occurrence in a cohort of patients treated with cimetidine.

Authors:  H Møller; K Lindvig; R Klefter; J Mosbech; O Møller Jensen
Journal:  Gut       Date:  1989-11       Impact factor: 23.059

7.  Survival after vagotomy: results of the Aarhus County Vagotomy Trial.

Authors:  S Ditlevsen
Journal:  World J Surg       Date:  1989 Nov-Dec       Impact factor: 3.352

8.  Histamine-2-receptor antagonists and gastric cancer risk.

Authors:  C La Vecchia; E Negri; B D'Avanzo; S Franceschi
Journal:  Lancet       Date:  1990-08-11       Impact factor: 79.321

9.  Mortality caused by stomach cancer after remote partial gastrectomy for benign conditions: 40 years of follow up of an Amsterdam cohort of 2633 postgastrectomy patients.

Authors:  G J Offerhaus; A C Tersmette; K Huibregtse; J van de Stadt; K W Tersmette; T Stijnen; P J Hoedemaeker; J P Vandenbroucke; G N Tytgat
Journal:  Gut       Date:  1988-11       Impact factor: 23.059

Review 10.  Time trends in incidence rates of first hip fracture in the Uppsala Health Care Region, Sweden, 1965-1983.

Authors:  T Naessén; R Parker; I Persson; M Zack; H O Adami
Journal:  Am J Epidemiol       Date:  1989-08       Impact factor: 4.897

View more
  6 in total

Review 1.  How Schwann cells facilitate cancer progression in nerves.

Authors:  Sylvie Deborde; Richard J Wong
Journal:  Cell Mol Life Sci       Date:  2017-06-19       Impact factor: 9.261

2.  Denervation suppresses gastric tumorigenesis.

Authors:  Chun-Mei Zhao; Yoku Hayakawa; Yosuke Kodama; Sureshkumar Muthupalani; Christoph B Westphalen; Gøran T Andersen; Arnar Flatberg; Helene Johannessen; Richard A Friedman; Bernhard W Renz; Arne K Sandvik; Vidar Beisvag; Hiroyuki Tomita; Akira Hara; Michael Quante; Zhishan Li; Michael D Gershon; Kazuhiro Kaneko; James G Fox; Timothy C Wang; Duan Chen
Journal:  Sci Transl Med       Date:  2014-08-20       Impact factor: 17.956

Review 3.  Why is the coexistence of gastric cancer and duodenal ulcer rare? Examination of factors related to both gastric cancer and duodenal ulcer.

Authors:  Hideyuki Ubukata; Hiroyuki Nagata; Takanobu Tabuchi; Satoru Konishi; Teruhiko Kasuga; Takafumi Tabuchi
Journal:  Gastric Cancer       Date:  2011-01-20       Impact factor: 7.370

4.  Helicobacter pylori-induced damage to the gastric mucosa is not modulated by previous vagotomy or medical treatment of peptic ulcer disease: a comparative study of vagotomized patients, medically treated peptic ulcer patients and community control subjects.

Authors:  Rolv-Ole Lindsetmo; Tor Jac Eide; Roar Johnsen; Arthur Revhaug
Journal:  World J Surg       Date:  2008-10       Impact factor: 3.352

Review 5.  The Role of the Vagus Nerve in Cancer Prognosis: A Systematic and a Comprehensive Review.

Authors:  Marijke De Couck; Ralf Caers; David Spiegel; Yori Gidron
Journal:  J Oncol       Date:  2018-07-02       Impact factor: 4.375

Review 6.  Vagotomy and Gastric Tumorigenesis.

Authors:  Hanne-Line Rabben; Chun-Mei Zhao; Yoku Hayakawa; Timothy C Wang; Duan Chen
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.